4.7 Article

Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development

Mei Lu et al.

Summary: The COVID-19 pandemic and mRNA vaccine development have brought nucleic acid therapeutics to the forefront. Nucleic acid drugs have shown promise in treating diseases at the genetic level, offering new treatment options and vaccine development against emerging health threats. However, challenges such as unfavorable physicochemical characteristics and off-target toxicity need to be addressed to advance nucleic acid therapeutics from the laboratory to clinical use.

ACCOUNTS OF CHEMICAL RESEARCH (2023)

Article Multidisciplinary Sciences

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia

Bo Hu et al.

Summary: A series of ionizable lipid-like materials were designed to develop a thermostable siRNA delivery system. The optimized formulation showed dose and time dual-dependent gene silencing and effectively reduced serum cholesterol and triglyceride levels. This research holds significant value for the treatment of hyperlipidemia and prevention of metabolic diseases.

SCIENCE ADVANCES (2022)

Article Pharmacology & Pharmacy

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy

Jiulong Zhang et al.

Summary: A versatile ICD amplifier was developed to enhance tumor immunotherapy by amplifying the eat me signal during tumor immunogenic cell death cascade. The amplifier enables chemotherapy-sensitized immuno-therapy and activates immune response against tumors.

ACTA PHARMACEUTICA SINICA B (2022)

Article Chemistry, Multidisciplinary

A Photoactivatable Silencing Extracellular Vesicle (PASEV) that Sensitizes Cancer Immunotherapy

Mei Lu et al.

Summary: This study developed a photoactivatable silencing extracellular vesicle (PASEV) for sensitized cancer immunotherapy. The PASEV effectively targets PAK4 in tumor cells and enhances intratumoral infiltration and immune activation through immunogenic phototherapy. It offers great promise for fighting cancers by eliciting robust anticancer immunity.

ADVANCED MATERIALS (2022)

Review Pharmacology & Pharmacy

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy

Yanyan Xu et al.

Summary: Cancer immunotherapy has flourished and revolutionized tumor therapies, but challenges such as low patient response rates and immune-related side effects remain. The immunosuppressive tumor microenvironment (TME) plays a pivotal role in tumor progression and metastasis, but also provides targets for remodeling the TME. Remodeling the TME and strengthening patients' immune systems can improve the effectiveness of immunotherapy.

ACTA PHARMACEUTICA SINICA B (2022)

Article Biotechnology & Applied Microbiology

Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities

Tae Kon Kim et al.

Summary: This article discusses the mechanisms used by tumors to evade the immune system, collectively known as adaptive immune resistance (AIR), and emphasizes the importance of defining AIR mechanisms in the tumor microenvironment for immunotherapy development.

NATURE REVIEWS DRUG DISCOVERY (2022)

Review Oncology

Combination strategies to maximize the benefits of cancer immunotherapy

Shaoming Zhu et al.

Summary: This review discusses the relationship between cancer immune response and resistance mechanisms to immunotherapy, as well as provides a comprehensive overview of the latest clinical status and FDA-approved combination therapies. It also covers therapies targeting cytokines, immunotherapy, virotherapy, innate immune modifiers, and cancer vaccines, as well as insights from the 2020 China Immuno-Oncology Workshop.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Pharmacology & Pharmacy

Nucleic acid delivery with extracellular vesicles

Michaela Schulz-Siegmund et al.

Summary: Extracellular vesicles (EVs) are membrane-enclosed particles that play physiological roles as mediators for transmitting molecular information between cells. They have potential applications for delivering nucleic acids, but challenges remain in terms of stability/protection and uptake efficacy. Research focuses on the roles of EVs in biology and pathology, as well as technical strategies for nucleic acid delivery.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Engineering, Biomedical

Bioinspired exosome-like therapeutics and delivery nanoplatforms

Mei Lu et al.

BIOMATERIALS (2020)

Article Chemistry, Multidisciplinary

Viral Protein-Pseudotyped and siRNA-Electroporated Extracellular Vesicles for Cancer Immunotherapy

Houli Liu et al.

ADVANCED FUNCTIONAL MATERIALS (2020)

Article Oncology

PAK4 inhibition improves PD-1 blockade immunotherapy

Gabriel Abril-Rodriguez et al.

NATURE CANCER (2020)

Review Chemistry, Multidisciplinary

Combining Nanomedicine and Immunotherapy

Yang Shi et al.

ACCOUNTS OF CHEMICAL RESEARCH (2019)

Review Nanoscience & Nanotechnology

Cancer nanomedicine for combination cancer immunotherapy

Jutaek Nam et al.

NATURE REVIEWS MATERIALS (2019)

Review Pharmacology & Pharmacy

Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems

Mei Lu et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

Review Pharmacology & Pharmacy

Exosome-based small RNA delivery: Progress and prospects

Mei Lu et al.

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

Article Pharmacology & Pharmacy

Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA

Mei Lu et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Review Pharmacology & Pharmacy

Recent advances on extracellular vesicles in therapeutic delivery: Challenges, solutions, and opportunities

Mei Lu et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)

Review Biochemistry & Molecular Biology

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma et al.

Review Immunology

Immunogenic cell death in cancer and infectious disease

Lorenzo Galluzzi et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Oncology

A Breakthrough: Macrophage-Directed Cancer Immunotherapy

Charles D. Mills et al.

CANCER RESEARCH (2016)

Article Oncology

Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth

Omran Abu Aboud et al.

MOLECULAR CANCER THERAPEUTICS (2016)

Article Multidisciplinary Sciences

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

Stefani Spranger et al.

NATURE (2015)

Review Oncology

PAK signalling during the development and progression of cancer

Maria Radu et al.

NATURE REVIEWS CANCER (2014)

Review Oncology

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko et al.

NATURE REVIEWS CANCER (2012)

Review Oncology

p21-activated kinases in cancer

Rakesh Kumar et al.

NATURE REVIEWS CANCER (2006)